Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 2/20 | 0.56 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.56 |
| ▸ | NFE2L2 | Q16236 | 10/20 | 0.52 |
| ▸ | PIN1 | Q13526 | 2/20 | 0.44 |
| ▸ | RELA | Q04206 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | NQO2 | P16083 | 1/20 | 0.41 |
| ▸ | FBP1 | P09467 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7546224 | 1.00 | CHRNB2 (0.56) | CHRNB2CHRNA4NFE2L2PIN1RELA | |
| SCHEMBL6255116 | 0.81 | CHRNB2 (0.56) | CHRNB2CHRNA4 | |
| SCHEMBL6253226 | 0.81 | CHRNB2 (0.56) | CHRNB2CHRNA4 | |
| SCHEMBL6255110 | 0.81 | CHRNB2 (0.56) | CHRNB2CHRNA4 | |
| SCHEMBL6253108 | 0.81 | CHRNB2 (0.56) | CHRNB2CHRNA4 | |
| SCHEMBL6253231 | 0.81 | CHRNB2 (0.56) | CHRNB2CHRNA4 | |
| SCHEMBL6253103 | 0.81 | CHRNB2 (0.56) | CHRNB2CHRNA4 | |
| SCHEMBL6255028 | 0.79 | GRIK1 (0.55) | CHRNB2CHRNA4NFE2L2RELANQO2 | |
| SCHEMBL7546225 | 0.79 | CHRNB2 (0.54) | CHRNB2CHRNA4 | |
| SCHEMBL6255032 | 0.79 | GRIK1 (0.55) | CHRNB2CHRNA4NFE2L2RELANQO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1214288-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE | Targacept Inc. (US) | 2002-06-19 | — | — | EP | claimed |
| US-6337351-B1 | AROMATIC OLEFIN AMINES | TARGACEPT, INC. | 2002-01-08 | — | — | US | claimed |
| WO-2001017943-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE | TARGACEPT, INC. (US) | 2001-03-15 | — | — | WO | claimed |
| EP-1214288-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE | Targacept Inc. (US) | 2002-06-19 | — | — | EP | disclosed |
| EP-1214288-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE | Targacept Inc. (US) | 2002-06-19 | — | — | EP | disclosed |
| US-6337351-B1 | AROMATIC OLEFIN AMINES | TARGACEPT, INC. | 2002-01-08 | — | — | US | disclosed |
| US-6337351-B1 | AROMATIC OLEFIN AMINES | TARGACEPT, INC. | 2002-01-08 | — | — | US | disclosed |
| WO-2001017943-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE | TARGACEPT, INC. (US) | 2001-03-15 | — | — | WO | disclosed |
| WO-2001017943-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE | TARGACEPT, INC. (US) | 2001-03-15 | — | — | WO | disclosed |